A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2021

Primary Completion Date

January 20, 2022

Study Completion Date

January 20, 2022

Conditions
Eosinophilic GastritisEosinophilic Duodenitis
Interventions
DRUG

AK002

Lirentelimab (AK002) is a humanized non-fucosylated immunoglobulin G1(IgG1) monoclonal antibody directed against Siglec-8

OTHER

Placebo

Placebo

Trial Locations (76)

10029

Allakos Investigational Site, New York

11023

Allakos Investigational Site, Great Neck

19104

Allakos Investigational Site, Philadelphia

21061

Allakos Investigational Site, Glen Burnie

22031

Allakos Investigational Site, Fairfax

27157

Allakos Investigational Site, Winston-Salem

27599

Allakos Investigational Site, Chapel Hill

27607

Allakos Investigational Site, Raleigh

27710

Allakos Investigational Site, Durham

28027

Allakos Investigational Site, Concord

28204

Allakos Investigational Site, Charlotte

29646

Allakos Investigational Site, Greenwood

30328

Allakos Investigational Site, Sandy Springs

30342

Allakos Investigational Site, Atlanta

32081

Allakos Investigational Site, Ponte Vedra

32132

Allakos Investigational Site, Edgewater

32256

Allakos Investigational Site, Jacksonville

33125

Allakos Investigational Site, Miami

33351

Allakos Investigational Site, Sunrise

33511

Allakos Investigational Site, Brandon

33603

Allakos Investigational Site, Tampa

33612

Allakos Investigational Site, Tampa

34653

Allakos Investigational Site, New Port Richey

34741

Allakos Investigational Site, Kissimmee

35205

Allakos Investigational Site, Birmingham

37212

Allakos Investigational Site, Nashville

37343

Allakos Investigational Site, Hixson

37421

Allakos Investigational Site, Chattanooga

38138

Allakos Investigational Site, Germantown

39232

Allakos Investigational Site, Flowood

43210

Allakos Investigational Site, Columbus

44060

Allakos Investigational Site, Mentor

44145

Allakos Investigational Site, Westlake

45066

Allakos Investigational Site, Springboro

45229

Allakos Investigational Site, Cincinnati

45415

Allakos Investigational Site, Dayton

48104

Allakos Investigational Site, Ann Arbor

49519

Allakos Investigational Site, Wyoming

52242

Allakos Investigational Site, Iowa City

55905

Allakos Investigational Site, Rochester

59901

Allakos Investigational Site, Kalispell

60611

Allakos Investigational Site, Chicago

63106

Allakos Investigational Site, Bay Saint Louis

64108

Allakos Investigational Site, Kansas City

66160

Allakos Investigational Site, Kansas City

70526

Allakos Investigational Site, Crowley

71105

Allakos Investigational Site, Shreveport

73102

Allakos Investigational Site, Oklahoma City

76092

Allakos Investigational Site, Southlake

76104

Allakos Investigational Site, Fort Worth

76301

Allakos Investigational Site, Wichita Falls

77598

Allakos Investigational Site, Webster

78229

Allakos Investigational Site, San Antonio

78757

Allakos Investigational Site, Austin

79410

Allakos Investigational Site, Lubbock

79905

Allakos Investigational Site, El Paso

84065

Allakos Investigational Site, Riverton

84092

Allakos Investigational Site, Sandy City

84112

Allakos Investigational Site, Salt Lake City

84405

Allakos Investigational Site, Ogden

85021

Allakos Investigational Site, Phoenix

85234

Allakos Investigational Site, Gilbert

85250

Allakos Investigational Site, Scottsdale

89511

Allakos Investigational Site, Reno

90808

Allakos Investigational Site, Long Beach

91910

Allakos Investigational Site, Chula Vista

93003

Allakos Investigational Site, Ventura

94598

Allakos Investigational Site, Walnut Creek

98115

Allakos Investigational Site, Seattle

98122

Allakos Investigational Site, Seattle

06010

Allakos Investigational Site, Bristol

02111

Allakos Investigational Site, Boston

02215

Allakos Investigational Site, Boston

03756

Allakos Investigational Site, Lebanon

07932

Allakos Investigational Site, Florham Park

07728

Allakos Investigational Site, Freehold

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allakos Inc.

INDUSTRY

NCT05152563 - A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis | Biotech Hunter | Biotech Hunter